- ICH GCP
- Registro de ensayos clínicos de EE. UU.
- Ensayo clínico NCT02223962
Effects of Physical Activity Counseling After an Exacerbation in COPD
The Effects of a Physical Activity Counseling Program Immediately After an Exacerbation in Patients With COPD.
Descripción general del estudio
Estado
Condiciones
Intervención / Tratamiento
Descripción detallada
After signing the informed consent, the patients will be randomized into a control group, receiving usual care, or the intervention group receiving real-time feedback and physical activity counseling.
Intervention: Physical activity counseling will be provided by 3 weekly telephone contacts based on the step count from the Fitbit Ultra. In agreement with the patient and based on the step counts a patients provided, a new goal for the next week was set. The goal was to strive for the highest possible level of physical activity during one month.
Tipo de estudio
Inscripción (Actual)
Fase
- No aplica
Contactos y Ubicaciones
Ubicaciones de estudio
-
-
-
Leuven, Bélgica, 3000
- University Hospital Leuven
-
-
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
Acepta Voluntarios Saludables
Géneros elegibles para el estudio
Descripción
Inclusion Criteria:
- Signed Informed Consent
- Chronic Obstructive Lung Disease (Tiff<70%)
- Hospitalized because of exacerbation
- Capable of working with electronic devices
Exclusion Criteria:
- Orthopedic/Neurologic problems making it difficult to be active
- Participation in a rehabilitation program
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Tratamiento
- Asignación: Aleatorizado
- Modelo Intervencionista: Asignación paralela
- Enmascaramiento: Único
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
|---|---|
|
Experimental: Physical activity
The fitbit Ultra was used to provide real-time feedback on physical activity.
An experienced physiotherapist contacted the subjects 3 times a week to receive information about the amount of steps from the previous days.
In agreement with the patient, a new goal for the coming weeks was set and patients were motivated to achieve their individual goal.
|
Counseling about physical activity will only be provided in the intervention group by 3 weekly telephone contacts.
Based on the information the physiotherapist receives, he or she will adapt the goal (in agreement with the patient) and motivate the patient to reach the individual goal.
|
|
Comparador de placebos: Usual Care
During the hospital stay, the patients in the control group will be informed about the beneficial effects of being physically inactive.They will not receive feedback about their activities performed and will not be stimulated to become more active.
|
Counseling about physical activity will only be provided in the intervention group by 3 weekly telephone contacts.
Based on the information the physiotherapist receives, he or she will adapt the goal (in agreement with the patient) and motivate the patient to reach the individual goal.
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Improvement in physical activity
Periodo de tiempo: 1 month
|
The Dynaport MoveMonitor, a valid device in patients with COPD, was used to accurately measure the level of physical activity.
The device was provided 3 times to the patients (baseline, after 2 weeks, after 1 month).
The amount of steps, measured by this device, was used as the outcome measure.
|
1 month
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Improvement in functional exercise capacity
Periodo de tiempo: 1 month
|
Functional exercise capacity was measured by the six minutes walking distance test (6MWD; meter).
This measurement was performed at baseline and after 1 month.
|
1 month
|
Colaboradores e Investigadores
Patrocinador
Publicaciones y enlaces útiles
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio
Finalización primaria (Actual)
Finalización del estudio (Actual)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Estimar)
Actualizaciones de registros de estudio
Última actualización publicada (Estimar)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Palabras clave
Otros números de identificación del estudio
- S55086
- ML8991 (Otro identificador: University Hospital Leuven)
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .